% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Lei:210385,
author = {X. Lei and I. Khatri and T. de Wit and I. de Rink and M.
Nieuwland and R. Kerkhoven and H. van Eenennaam and C.
Sun$^*$ and A. D. Garg and J. Borst and Y. Xiao},
title = {{CD}4+ helper {T} cells endow c{DC}1 with cancer-impeding
functions in the human tumor micro-environment.},
journal = {Nature Communications},
volume = {14},
number = {1},
issn = {2041-1723},
address = {[London]},
publisher = {Nature Publishing Group UK},
reportid = {DKFZ-2023-00114},
pages = {217},
year = {2023},
abstract = {Despite their low abundance in the tumor microenvironment
(TME), classical type 1 dendritic cells (cDC1) play a
pivotal role in anti-cancer immunity, and their abundance
positively correlates with patient survival. However, their
interaction with CD4+ T-cells to potentially enable the
cytotoxic T lymphocyte (CTL) response has not been
elucidated. Here we show that contact with activated CD4+
T-cells enables human ex vivo cDC1, but no other DC types,
to induce a CTL response to cell-associated tumor antigens.
Single cell transcriptomics reveals that CD4+ T-cell help
uniquely optimizes cDC1 in many functions that support
antigen cross-presentation and T-cell priming, while these
changes don't apply to other DC types. We robustly identify
'helped' cDC1 in the TME of a multitude of human cancer
types by the overlap in their transcriptomic signature with
that of recently defined, tumor-infiltrating DC states that
prove to be positively prognostic. As predicted from the
functional effects of CD4+ T-cell help, the transcriptomic
signature of 'helped' cDC1 correlates with tumor
infiltration by CTLs and Thelper(h)-1 cells, overall
survival and response to PD-1-targeting immunotherapy. These
findings reveal a critical role for CD4+ T-cell help in
enabling cDC1 function in the TME and may establish the
helped cDC1 transcriptomic signature as diagnostic marker in
cancer.},
keywords = {Humans / CD8-Positive T-Lymphocytes / Neoplasms: metabolism
/ Antigen Presentation / T-Lymphocytes, Cytotoxic /
Dendritic Cells / T-Lymphocytes, Helper-Inducer: metabolism
/ Tumor Microenvironment},
cin = {D250},
ddc = {500},
cid = {I:(DE-He78)D250-20160331},
pnm = {314 - Immunologie und Krebs (POF4-314)},
pid = {G:(DE-HGF)POF4-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36639382},
pmc = {pmc:PMC9839676},
doi = {10.1038/s41467-022-35615-5},
url = {https://inrepo02.dkfz.de/record/210385},
}